Your browser doesn't support javascript.
loading
Morphological changes and their associations with clinical parameters in children with nephropathic cystinosis and chronic kidney disease prior to kidney replacement therapy over 25 years.
Brügelmann, Malina; Müller, Sophia; Bohlen, Alina V; Hohenfellner, Katharina; Büscher, Anja; Kemper, Markus J; Fröde, Kerstin; Kanzelmeyer, Nele; Oh, Jun; Billing, Heiko; Gellermann, Jutta; Müller, Dominik; Weber, Lutz T; Acham-Roschitz, Birgit; Arbeiter, Klaus; Tönshoff, Burkhard; Hagenberg, Martina; Zebec, Mislav S; Haffner, Dieter; Zivicnjak, Miroslav.
Affiliation
  • Brügelmann M; Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School Children's Hospital, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
  • Müller S; Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School Children's Hospital, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
  • Bohlen AV; Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School Children's Hospital, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
  • Hohenfellner K; Division of Pediatric Nephrology, Children's Hospital, Rosenheim, Germany.
  • Büscher A; Department of Pediatrics II, University Hospital Essen, Essen, Germany.
  • Kemper MJ; Asklepios Hospital, Hamburg, Germany.
  • Fröde K; Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School Children's Hospital, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
  • Kanzelmeyer N; Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School Children's Hospital, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
  • Oh J; Department of Pediatric Nephrology, University Children's Hospital Hamburg, Hamburg, Germany.
  • Billing H; Clinic for Pediatric and Adolescent Medicine, RHK Clinic Ludwigsburg, Ludwigsburg, Germany.
  • Gellermann J; Department of Pediatric Gastroenterology, Nephrology and Metabolic Diseases, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Müller D; Department of Pediatric Gastroenterology, Nephrology and Metabolic Diseases, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Weber LT; Pediatric Nephrology, Faculty of Medicine and University Hospital, Children's and Adolescents' Hospital, University of Cologne, Cologne, Germany.
  • Acham-Roschitz B; Department of Pediatrics, Medical University Graz, Graz, Austria.
  • Arbeiter K; Division of Pediatric Nephrology and Gastroenterology, Medical University Vienna, Vienna, Austria.
  • Tönshoff B; Department of Pediatrics I, University Children's Hospital Heidelberg, Heidelberg, Germany.
  • Hagenberg M; Children's Hospital St. Elisabeth and St. Barbara, Halle (Saale), Germany.
  • Zebec MS; Institute for Anthropological Research, Zagreb, Croatia.
  • Haffner D; Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School Children's Hospital, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
  • Zivicnjak M; Department of Pediatric Kidney, Liver and Metabolic Diseases, Hannover Medical School Children's Hospital, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. zivicnjak.miroslav@mh-hannover.de.
Pediatr Nephrol ; 2024 Jun 08.
Article in En | MEDLINE | ID: mdl-38850407
ABSTRACT

BACKGROUND:

Infantile nephropathic cystinosis (INC) is a rare lysosomal storage disorder, mostly and often firstly affecting the kidneys, together with impaired disharmonious growth and rickets, eventually resulting in progressive chronic kidney disease (CKD). With the introduction of cysteamine therapy, most pediatric patients reach adulthood with no need for kidney replacement therapy. Still, detailed changes in INC patients' clinical and morphological presentation over the past decades have not yet been thoroughly investigated.

METHODS:

Two groups with a respective total of 64 children with INC and 302 children with CKD, both treated conservatively and aged 2 to 18 years, were prospectively observed in the time span from 1998 to 2022 with 1186 combined annual clinical and morphological examinations clustered into two measurement periods (1998 to 2015 and ≥ 2016).

RESULTS:

In INC patients, thoracic proportion indices remained markedly increased, whereas body fat stores remained decreased over the past 25 years (+ 1 vs. below ± 0 z-score, respectively). Their CKD peers presented with overall improved growth, general harmonization of body proportions, and improved body fat stores, while INC patients only presented with an isolated significant increase in leg length over time (∆0.36 z-score). eGFR adjusted for age did not significantly change over the past 25 years in both groups. Alkaline phosphatase (ALP) showed a significant decrease in CKD patients over time, while remaining above normal levels in INC patients.

CONCLUSIONS:

Disproportionate thoracic shape and impaired body fat stores remain the most characteristic morphological traits in INC patients over the past 25 years, while causal mechanisms remain unclear.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pediatr Nephrol Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pediatr Nephrol Year: 2024 Document type: Article